Independent research • Source-backed profiles • No paid rankings
Peptide Provider Direct
Steel City HRT & Weight Loss logo
License information checked7 services cataloged

Steel City HRT & Weight Loss

Virtual provider · Telehealth available

Visit provider website ↗

Provider overview

About Steel City HRT & Weight Loss

Steel City HRT & Weight Loss is a solo-provider telehealth practice operated by Steel City Men's Health and Testosterone LLC and led by Jeremiah Velasquez, FNP-BC, AGACNP-BC. Its official site reports care in Arizona, Colorado, Idaho, Maine, Montana, New Hampshire, New Mexico, Washington, and Wyoming. Published programs include growth-hormone-peptide optimization, testosterone care, women's hormone care, semaglutide- and tirzepatide-related metabolic care, low-dose naltrexone, and required laboratory monitoring. The active CMS NPI record supports Velasquez's nurse practitioner identity. The provider discloses use of licensed 503A pharmacies but does not identify a facility on the reviewed pages; no pharmacy identity or 503A classification is inferred here, and compounded drugs are not FDA approved.

At a glance

Market role
Telehealth platform / connector
Care model
Telehealth
Coverage
9 listed jurisdictions
Pharmacy pathway
Not publicly established
Medical weight managementHormone healthLongevity medicineMetabolic healthLaboratory testingRecovery support

503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.

Service catalog

Programs and services

Provider-advertised services, grouped for quick scanning with all details visible.

7 cataloged
01

Peptide-related care

1

Growth-hormone peptide optimization

The practice advertises clinician-prescribed growth-hormone-peptide protocols with IGF-1 monitoring; compound identity and availability require confirmation.

Provider source ↗
02

Hormone health

2

Testosterone replacement therapy

Lab-driven injectable, topical, or oral testosterone pathways are advertised for clinically evaluated patients.

Provider source ↗

Hormone therapy for women

The provider advertises estradiol, progesterone, and testosterone protocols based on individual evaluation and laboratory findings.

Provider source ↗
03

GLP-1 and metabolic programs

1

Semaglutide and tirzepatide metabolic program

These medications are named within the GLP-1 program; eligibility, formulation, indication, and availability require clinician confirmation.

Provider source ↗
04

Additional services

1

Low-dose naltrexone program

Clinician-managed compounded LDN is listed for evaluated patients; promoted outcomes are not adopted as facts.

Provider source ↗
05

Laboratory services

1

Baseline and follow-up laboratory monitoring

The clinic requires program-specific baseline panels and follow-up testing, including IGF-1 monitoring for peptide care.

Provider source ↗
06

Care model

1

Nine-state telehealth care

The current official site limits telehealth to patients physically located in nine named licensed states at the visit.

Provider source ↗
Important: Inclusion does not establish availability for every patient or state, regulatory status, clinical appropriateness, safety, or effectiveness.

Coverage and research

Explore this provider’s markets

Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.

ArizonaColoradoIdahoMaineMontanaNew HampshireNew MexicoWashingtonWyoming
Sermorelin research guide →Lab testing in peptide programs →Researching longevity claims →

Continue comparing

Related provider profiles

Advanced Spine and Pain ClinicsAnderson Longevity ClinicAnti-Aging Northwest

Evidence

Sources reviewed

Logo reproduced from the provider’s official website for identification. Logo source ↗

These links support the public facts recorded here. Provider-published information is not an independent endorsement.